Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts

Figure 2

Comparison of topo I staining in cultured fibroblasts of normal controls and SSc patients. A. Topo I immunostaining with anti-topo I monoclonal antibodies showed multiple speckles in the nucleoplasm of SSc fibroblasts, which is differentiated from that in normal fibroblasts (relatively homogenous stain of topo I) at both 7 and 14 days of cultures. Some SSc fibroblasts show cytoplasmic staining of topo I protein (marked with red arrow heads). B. Topo I immunostaining with anti-topo I positive sera from SSc patients show the expected nuclear/nucleolar staining as well as cytoplasmic staining of SSc fibroblasts. At Day 14, the cytoplasmic staining appeared to increase relative to the nucleoplasm and nucleolar staining.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us